Home·Supplements·Mitocondria·Coenzyme Q10
II.·ii. Mitochondria · 1 of 6

Coenzyme Q10 ubiquinol cardio-protector

Essential component of the electron transport chain · endogenous synthesis drops 50% post-60 years. Q-SYMBIO trial: −43% CV mortality in heart failure with 300 mg/day × 2 years. Critical in statin users (induced Q10 depletion up to 40%).

Robust evidence100–300 mgubiquinol/dayWith fatty meal3× absorption~30 €/monthKaneka®
6Coenzyme Q10 appears in 6 protocols personalizable
Optimal dose
100–300 mg
ubiquinol with food
Best form
Ubiquinol
>60 years or statin
Hallmarks
Mito · CV
3 of 12 hallmarks
Critical if
Statins
40% Q10 depletion
i.

What is Coenzyme Q10

Lipid-soluble lipoquinone · essential component of mitochondrial electron transport chain · endogenous synthesis drops 50% with age + statin depletion.

Coenzyme Q10 (CoQ10, ubiquinone) is a lipid-soluble lipoquinone present in ALL cells of the body, with maximum concentrations in high-energy-demand organs: heart, brain, liver, kidney. It's an essential cofactor of Complex I, II and III of the mitochondrial electron transport chain · without sufficient Q10, ATP production falls significantly.

Exists in two interconvertible forms: ubiquinone (oxidized form) and ubiquinol (reduced form). Ubiquinol is the biologically active form that captures free radicals + transfers electrons · young adults maintain 95% ubiquinol / 5% ubiquinone ratio · post-60 years the ratio inverts towards more ubiquinone (worse function).

Endogenous synthesis drops 50% post-60 years + is directly inhibited by statins (HMG-CoA reductase is also limiting step in Q10 synthesis). Chronic statin users may lose 30-40% of muscle Q10 · partially explains statin-induced myopathy.

«If you're taking statins and NOT supplementing CoQ10 ubiquinol, you're paying cardiovascular prevention with mitochondrial function · it's the most life-day-saving decision a statin user can make.» Stephen Sinatra · MD · Cardiology · The Sinatra Solution
−43%
cardiovascular mortality with CoQ10 300 mg/day in heart failure class III-IV patients · 2-year Q-SYMBIO trial.
Source · Mortensen · JACC Heart Fail 2014
ii.

Clinical evidence · cardio + mitochondria

5 pivotal studies · cardinal Q-SYMBIO trial in heart failure + CV events meta-analysis + statin-Q10.

StudyFindingHallmarks
Q-SYMBIO · CoQ10 in heart failure
Mortensen et al · JACC Heart Fail 2014
2-year RCT · n=420 HF class III-IV · 300 mg/day CoQ10 vs placebo · −43% CV mortality, −42% MACE, −44% CV hospitalizations. NYHA class improvement. Effect independent of optimal pharmacotherapy.CVMortality
CoQ10 and statin-induced myopathy
Mancuso et al · CNS Neurol Disord Drug Targets 2010
Meta 7 RCTs · n=479 patients with statin-induced myalgia · 100-200 mg/day CoQ10 significantly reduced muscle pain and plasma CK vs placebo. Mechanism: reverse muscle Q10 depletion.MuscleStatin
Ubiquinol vs Ubiquinone · bioavailability
Hosoe et al · Regul Toxicol Pharmacol 2007
Crossover n=22 · 100 mg ubiquinol raises plasma Q10 1.8× faster and 2.0× higher than same ubiquinone dose · especially significant in elders 60+ (with less capacity to reduce ubiquinone→ubiquinol).BioavailabilityAge
CoQ10 + selenium · elderly mortality
Alehagen et al · PLoS One 2015
KiSel-10 RCT · n=443 elders 70-88 years · 4 years · 200 mg CoQ10 + 200 µg selenium: −53% CV mortality, cardiac function improvement on echocardio. Necessary combo (Q10 without Se doesn't work in Se-deficient).MortalitySynergy
Meta-analysis CoQ10 in hypertension
Rosenfeldt et al · J Hum Hypertens 2007
Meta 12 RCTs · n=362 hypertensives · 100-225 mg/d CoQ10 reduced systolic pressure 11 mmHg and diastolic 7 mmHg · effect independent of other antihypertensives. Mechanism: endothelial vasodilation + vascular muscle mitochondrial function.HypertensionEndothelium
My Protocol · free

Is Coenzyme Q10 right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (3)Not impacted (7)
iv.

CoQ10 dose · how much, when and how

Protocol based on use · general cardio-protection 100-200 mg · clinical HF 300 mg · always with fatty meal.

Prevention<60 years no statins

Maintenance

100 mg ubiquinol / day with food

For general mitochondrial support in young-middle adults with adequate endogenous synthesis. Take with dinner (highest fat meal of day). Ubiquinone (standard form) also works at <60 years.

Cardio + age>60 years or statins

Therapeutic dose

200 mg ubiquinol / day

Ubiquinol mandatory · capacity to reduce ubiquinone drops with age. Divide in 2 doses (100 mg breakfast + 100 mg dinner) for better plasma stability. Critical if you take statins.

Heart failureUnder cardio supervision

Q-SYMBIO protocol

300 mg ubiquinol / day (3×100)

Q-SYMBIO trial dose · only under cardiological supervision. Effects on NYHA class + mortality at 6-12 months. DOES NOT replace pharmacotherapy (ACEIs, beta-blockers, ARNI) · it's complementary.

CofactorsLongevity stack

Selenium + PQQ combo

+ 200 µg selenium + 10 mg PQQ

Selenium mandatory cofactor (KiSel-10 trial 2015) · PQQ promotes mitochondrial biogenesis (Q10 loads existing + PQQ creates new). Complete pro-mitochondrial stack.

v.

Ubiquinone vs Ubiquinol · which to choose by age

Chemical form is CRITICAL · ubiquinol superior in elders 60+ and statin users. KP/Kaneka® brand is the ubiquinol gold-standard.

Ubiquinol (KP/Kaneka®)Reduced form · 2× bioavailability
ProsBioavailability 2× ubiquinone in >60 years. Form used in Q-SYMBIO trial. KP® from Kaneka is the only natural fermentation ubiquinol (not synthetic).
ConsExpensive · 2-3× ubiquinone price. Oxidation sensitive · softgel capsules with oil + nitrogen.
Ideal use: &gt;60 years · statin users · heart failure · any serious clinical case.
UbiquinoneOxidized form · standard
ProsCheaper · stable. Adequate bioavailability in young <60 with endogenous reduction capacity.
ConsBioavailability falls 50% in >60 years · ineffective in statin users · endogenous reduction capacity compromised.
Ideal use: young &lt;60 in good health · tight budget · no statins.
Water-soluble CoQ10 (Q-Max)Cyclodextrin-encapsulated
ProsBioavailability superior even to standard ubiquinol. «Q-Max» form allows absorption without fat.
ConsExpensive · limited Spain availability. Few serious brands.
Ideal use: patients with fat malabsorption · bariatric surgery · clinical hospital use.
vi.

Best CoQ10 / ubiquinol brands · Spain 2026

Absolute criterion · look for «Kaneka KP®» or «Kaneka Ubiquinol» in ingredient list. It's natural fermentation ubiquinol · rest are inferior synthetic ubiquinol.

Premium

Jarrow Formulas QH-Absorb Kaneka Ubiquinol

42 € · 60 softgels (2 months)

Dose: 100 mg Kaneka KP® ubiquinol/day

Form: Kaneka KP® ubiquinol · softgel with sunflower oil

Cert.: GMP · third-party tested · Kaneka authentic

Fillers: Sunflower oil + tocopherol antioxidant

Jarrow Distributor ESaffComing soonAmazon SpainaffComing soon
Medio

Doctor's Best Ubiquinol BioPQQ

32 € · 60 softgels (2 months)

Dose: 100 mg Kaneka KP® ubiquinol + 10 mg PQQ

Form: Ubiquinol + PQQ (mitochondrial biogenesis)

Cert.: GMP · Kaneka authentic

Fillers: Softgel with oil + non-GMO

iHerbaffComing soonAmazon SpainaffComing soon
Económica

NOW Foods CoQ10 100 mg (ubiquinone)

16 € · 90 softgels (3 months)

Dose: 100 mg ubiquinone/day

Form: Standard ubiquinone (NOT ubiquinol)

Cert.: GMP · NSF

Fillers: Flax oil · natural vitamin E

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

How to measure CoQ10 effect

3 biomarkers · one direct (plasma Q10), two indirect cardiovascular.

Plasma CoQ10. Direct marker · target >1.2 µg/mL (cardio-protective optimal range). Deficient <0.6 µg/mL. ~55 € in Spanish private analytics (Synlab · CTO). Useful pre/post supplementation to confirm absorption.

Cardiac function · echocardio. LVEF (left ventricular ejection fraction) in HF patients · improves ~3-7 points with CoQ10 at 6-12 months (Q-SYMBIO sub-analysis). Requires cardiological supervision.

Systolic blood pressure. Typical reduction 10 mmHg in hypertensives with elevated baseline (Rosenfeldt 2007 meta). Detectable change in 8-12 weeks with 200 mg/d ubiquinol.

Related analysis · verified clinics

CoQ10 + cardio-preventive echocardio panel in 14 clinics Spain

Complete cardio-preventive · CoQ10 plasma + LVEF echocardio + advanced lipid profile + Lp(a) + apoB. Particularly recommended if you take chronic statins.

14Verified clinics
120–250 €Price range
48hResults
4.8/5Average score
View 14 clinics →
viii.

Contraindications and interactions

Excellent safety profile · few but significant interactions with anticoagulants and antihypertensives.

Consult healthcare professional if
  • Warfarin anticoagulants: CoQ10 structurally similar to vitamin K · may REDUCE warfarin effect (raise INR target). Monitor INR at 2-4 weeks post-CoQ10 start. It's not absolute contraindication · it's dose adjustment. Consult cardiology →
  • Antihypertensives (ACEIs, ARBs): CoQ10 reduces blood pressure 10 mmHg · effects may be additive · monitor BP first 4-8 weeks. Possible need to reduce antihypertensive dose.
  • Insulin-treated diabetes: CoQ10 improves insulin sensitivity · monitor glucose first 4 weeks · possible insulin dose adjustment.
  • Chemotherapy (some): CoQ10 may interfere with chemotherapy operating via oxidative stress (specific alkylating). Consult oncology before supplementing.
  • Pregnancy and lactation: Limited data · no adverse effects reported but few studies. Consult before supplementing.
−40%
muscle Q10 in chronic statin users · induced depletion not measured in routine analytics · partially explains myalgia.
Source · Mancuso · CoQ10 statin meta 2010
x.

Frequently asked questions about CoQ10

8 real questions · literature-based answers.

Ubiquinol or ubiquinone?
Depends on age and health. <60 years healthy: ubiquinone sufficient (cheaper). >60 years or statins or HF: Kaneka KP® ubiquinol mandatory · endogenous capacity to reduce ubiquinone→ubiquinol drops with age. Ubiquinol always superior, but ubiquinone enough in young.
Why with fatty meal?
Q10 is fat-soluble · without fat absorption drops ~70%. With dinner containing fat (olive oil, avocado, fatty fish, nuts) absorption is maximum. Some brands come pre-formulated in oil (softgel) to mitigate this.
I take statins, do I need it?
Practically yes. Statins inhibit HMG-CoA reductase → blocks Q10 synthesis → 30-40% muscle Q10 depletion in 3-6 months · partially explains statin-induced myalgia (Mancuso 2010 meta). Minimum 100 mg ubiquinol/day.
How long to notice effects?
Energy/fatigue: 2-4 weeks. Blood pressure: 8-12 weeks. Statin myalgia: 4-8 weeks. HF cardiac function (LVEF): 6-12 months (Q-SYMBIO timeline).
Better morning or evening?
Doesn't matter · what matters is WITH FOOD. Some prefer morning (subjective effect more energy) · others with dinner (greater fat amount). Divide 2 doses (morning + dinner) optimizes plasma stability for doses >200 mg.
Does it cause insomnia?
Rarely. Some sensitive individuals report more energy and difficulty sleeping if they take high doses (200+ mg) in afternoon. Switching to morning intake solves it. Most don't notice sleep effect.
Is it safe long-term?
Yes · excellent safety profile in 30+ years clinical use. Doses up to 3,000 mg/day studied without red flags in short studies. For regular therapeutic dose (100-300 mg) literature is overwhelming.
Is there CoQ10 genetic deficiency?
Yes · CoQ10 primary deficiency (genetic) rare but exists · typically pediatric diagnosis. CoQ10 secondary deficiency (acquired by age/statins/disease) is common. Genetic test only justified in pediatric cases with mitochondrial encephalopathy.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →